Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIMERSEN vs ETEPLIRSEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASIMERSEN vs ETEPLIRSEN: Safety Overview

Metric CASIMERSEN ETEPLIRSEN
Total FAERS Reports 767 2,079
Deaths Reported 7 59
Death Rate 0.9% 2.8%
Hospitalizations 87 288
Average Patient Age 14.0 yrs 15.5 yrs
% Female Patients 0.4% 1.7%
FDA Approval Date Feb 25, 2021 Sep 19, 2016
Manufacturer Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc.
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription